Home › Forums › Main Forum › Media & News › AASLD: cost of manufacturing Sof/Dac treatment could be as low as US$80
Interesting video press release from Dr Andrew M. Hill at AASLD 2016.
http://www.healio.com/hepatology/hepatitis-c/news/online/{109cec7a-ae62-41db-b9c8-93f662b02912}/video-cost-to-treat-hcv-could-be-as-low-as-80-in-the-us
G3a since ’78 – Dx ’12 – F4 (2xHCC) 24wk Tx – PEG/Riba/Dac 2013 relapsed 24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed 16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof SVR7 – 22/06/17 UND SRV12 – 27/07/17 UND SVR24 – 26/10/17 UND